News & Updates

The treatment effect of omaveloxolone in halting progression, based on change in mFARS score, is particularly pronounced in individuals with Friedreich's ataxia who had disease onset at ≤15 years of age, suggests a post hoc subgroup analysis of MOXIe Part 2 presented at EAN 2024.

Individuals with type 1 diabetes (T1D) are at heightened risk or arrythmia, with a causal relationship between the two medical conditions demonstrated in a two-sample Mendelian randomization (MR) study.

The use of Janus kinase (JAK) inhibitors in the treatment of major autoimmune diseases appears to reduce the risk of age-related macular degeneration (AMD) for people above 40 years of age, according to a study.

In patients with obesity undergoing electrical cardioversion for atrial fibrillation (AF), dual direct-current cardioversion (DCCV) appears to be more effective at converting AF into sinus rhythm compared with single DCCV, as reported in a study.

Once-weekly treatment with HRS9531, a novel dual GLP-1* and GIP** receptor agonist, resulted in substantial reductions in body weight among Chinese patients with obesity, according to a study presented at ADA 2024.